Molecular Imaging Corporation

Mobile PET Systems has grown to be the leading mobile provider of Positron

Emission Tomography (PET) imaging services. Its 16 Mobile PET Systems

offer hospitals and other healthcare providers with cost-effective access

to state-of-the-art PET technology in the US, and Europe. The Company

currently provides PET services to 74 hospital and medical facilities.

The Company was recently granted accreditation from the Joint Commission

of Accreditation of Healthcare Organizations (JCAHO), recognizing that

Mobile PET Systems complies with rigorous national performance standards

Positron Emission Tomography (PET) is a molecular medical imaging procedure

that shows abnormalities based on tissue’s metabolism of glucose.

CT, MR and ultrasound, PET provides “functional” imaging. This

ability to give a direct measure of the body’s metabolic functions

gives PET many advantages over other diagnostic imaging techniques. "Functional

Imaging" can detect metabolic changes, which may be precursors to

disease. It can monitor response to treatment, as well as eliminate the

need for costly redundant testing or invasive surgical procedures.

in the detection of cancer. Malignant tumors in general are hypermetabolic

with glucose and stand out from normal tissues. PET’s unique ability

to image functional processes and detect hypermetabolic activity renders

it an effective noninvasive tool for detecting, staging and assessing

Cardiology - PET is an extremely valuable diagnostic tool for

cardiologists. It is the most accurate noninvasive test available to detect

the presence of coronary artery disease (CAD). Following coronary occlusion,

a portion of the myocardium may appear to be irreversibly infarcted, demonstrating

a wall motion abnormality while showing no evidence of perfusion on traditional

nuclear medicine scans. This “hibernating” myocardium will show

normal or hypermetabolism with glucose, indicating viability that with

evolve. Because Alzheimer’s disease displays hypo metabolism of glucose

in the brain’s parietal area, PET scanning depicts this brain disorder

with far greater accuracy than traditional “anatomic” imaging.

Many epileptic patients suffer from focal epilepsy that cannot be controlled

with medication but may benefit from surgical resection of the brain.

PET FDG imaging is a non-invasive and cost effective aid in predicting

the prognosis and surgical planning for resection procedures. PET helps

here for a short power point presentation which explains PET and it's

two major advantages over all other imaging modalities, detection and